оваленко ¬.Ќ., Ќесукай ≈.√. - Ќекоронарогенные болезни сердца. ѕрактическое руководство.

Houser S.R., Lakatta E.G. Function of the cardiac myocyte in the conundrum of end-stage, dilated human heart failure // Circulation. Ч 1999. Ч Vol. 99. Ч P. 600-604.

Hunter J.J., Chien K.R. Mechanisms of disease: signalling pathways for cardiac hypertrophy and failure // New Engl. J. Med. - 1999. - Vol. 341. Ч P. 1276-1283.

Hurrell D.G., Nishimura R.A., Higano S.T. et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis//Circulation. Ч 1996. Ч Vol. 93. Ч P. 2007.

Iaccarino G., Lefkowitz R.J., Koch W.J. Myocardial G protein-coupled receptor kinase: implications for heart failure therapy // Proc. Assoc. Am. Physicians. Ч 1999. - Vol. 111. - P. 399-405.

Ikram H. Identifying the patient with heart failure //J. Int. Med. Res. Ч 1995. Ч Vol. 23.-P. 139-153.

Ishyiama S., Hiroe M., Nishikawa T. et al. Inhibitory effects of vesnarione in the progression of myocardial damage in experimental autoimmune myocarditis in rats // Cardiovasc. Res. - 1999. - Vol. 43. - P. 389-397.

Jibiki “., Terai M. Expression of tumor necrosis factor-alpha protein in the myocardium in fatal myocarditis// Pediatr. Int. Ч 2000. Ч Vol. 42, є 1. Ч P. 43-47.

Johnson J.A. Diastolic dysfunction in congestive heart failure // Clin. Pharm. Ч 1991.-Vol. 10.-P. 850-861.

Johnson M.R., Gheorgiade M. Growth hormone therapy in patients with congestive heart failure: need for further research // Amer. Heart J. Ч 1999. Ч Vol. 137.-P. 899-901.

Jonsson B. Measurement of health outcome and associated costs in cardiovascular disease //Europ. Heart J.- 1996. - Vol. 17,Suppl.A. - P. 2-7.

Kandolf R., KirschnerP, AmeisD.etal. Enteroviral heart disease: diagnosis by in situ hybridization/Schultheiss H.P. ed. New concepts in viral Heart disease. Springer-Verlag, 1988. - P. 337-348.

Kandolf R., Klingel K., Mertsching H. et al. Molecular studies on enteroviral heart disease: pattern ofacute and persistent infection//Europ. HeartJ. Ч 1991. Ч Vol.12 (Suppl. D). - P. 49-55.

Kang PM., Izumo S. Apoptosis and heart failure: a critical review of literature // Circ. Res. - 2000. - Vol. 86. - P. 1107-1113.

Kasper E.K., Agema W.R.P., Huchins G.V. et al. The cause of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients //J. Amer. Coll. Cardiol. - 1994. - Vol. 23. - P. 586-590.

Keith M., Geranmayegan A., Sole M. et al. Increased oxidative stress in patients with congestive heart failure// J. Amer. Coll. Cardiol. - 1998. - Vol. 31. Ч P. 1352-1356.

King M.K., Gay D.M., Pan L.C. et al. Treatment with a growth hormone secretagogue in a model of developing heart failure // Circulation. Ч 2001. Ч Vol. 103.-P. 308-313.

Kinoshita O., Fontaine G., Rosas F. et al. Time- and frequency domain analysis of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia //Circulation. - 1995. - Vol. 91. - P. 715-721.

Klein J., Stanek G., Bittner R. et al. Lyme borreliosis as a cause of myocarditis and heart muscle disease //Europ. HeartJ.- 1991.-Vol. 12, Suppl. D. - P. 73-75.

Klingel K., Hohenadl C, Canu et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage and inflammation // Proc. Natl. Acad. Sci. USA. Ч 1992.-Vol. 89.-P. 314-318.

Knott-Craig C.J., Dalton R.P., Rossouw G.J., et al. Penetrating cardiac trauma: management strategy based on 129 surgical emergencies over 2 years//Ann. Thorac. Surg. - 1992. - Vol. 53. - P. 1006.

Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure // Cardiovasc. Res. - 1999. - Vol. 43. - P. 562-571.

Krown K., Page T.P., Nguyen C. et al. Tumour necrosis factor alpha-induced apoptosis in cardiac myocytes //J. Clin. Invest. - 1996. - Vol. 98. - P. 2854-2865.

Kubota X, McNamara D.M., Wang J.J. et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure // Circulation. Ч 1998. - Vol. 97. - P. 2499-2501.

LabibS., UdelsonJ.E., PandianN.G. Echocardiography in low pressure cardiac tamponade//Amer. J. Cardiol. - 1989. - Vol. 63. - P. 1156.

Laham R.J., Cohen D.J., Kuntz R.E. et al. Pericardial effusion in patients with cancer: outcome with contemporary management strategies // Heart. Ч 1996. Ч Vol. 75. - P. 67.

Lang K., Borner A., Figulla H. Comparison ofbiochemical markers for the detection of minimal myocardial injury: superior sensitivity of cardiac troponin-T//J. Intern. Med. - 2000. - V 247. - є 1. - P. 119-123.

Lechat P. Prevention of heart failure progression: current approaches // Eur. Heart J. Ч 1998. - Vol. 19, Suppl. B. - P. 12-18.

Leclercq J.F., Coumel P. Late potentials in arrhythmogenic right ventricular dysplasia//Europ. Heart J.- 1993.-Vol. 14, Suppl. H. - P. 67-93.

Leport C. Antibiotic prophylaxis for infective endocarditis // Clin. Microbiol Infect. - 1998. - Vol. 4. - P. 56-61.

Levin S., Maldonada I., Rehm C. et al. Cardiac tamponade without pericardial effusion after blunt chest trauma //Amer. Heart J.Ч 1996. ЧVol. 131. Ч P. 198.

Levine M.J., Lorell B.H., DiverD.J. etal. Implicationsofechocardiographically assisted diagnosis of pericardial tamponade in contemporary medical patients: detection before hemodynamic embarrassment//J. Amer. Coll. Cardiol. Ч 1991. Ч Vol. 17.-P. 59.

Levy D., Larson M.G., Vasan R.S. et al. The progression from hypertension to congestive heart failure //J. A. M. A. - 1996. - Vol. 275. - P. 1557-1562.

Li Y, Peng “., Yang Y High prevalence of enteroviral genomic sequences in myocardium// Heart. Ч 2000. Ч V. 83, є 6. - P. 696-701.

Lie J.T. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease //Ann. Int. Med. Ч 1988. Ч Vol. 109. Ч P. 25-28.

Lieberman E.B., Hutchins G.M., Herskowitz A. et al. A clinicopathologic description of myocarditis//J. Amer. Coll. Cardiol. Ч 1991. Ч Vol. 18. Ч P. 1617-1626.

Lindner J. R., Case R.A., Dent J.M. etal. Diagnostic value of echocardiography in suspected endocarditis // Circulation. Ч 1996. Ч Vol. 93. Ч P. 730-736.

Lobo F.V., Heggtveit H.A., Butany J. et al. Right ventricular dysplasia: morphological findings in 13 cases//Can. J. Cardiol. Ч 1992. Ч Vol. 8. Ч P. 261-268.

Lorell B.H. Left ventricular hypertrophy and diastolic dysfunction // Hosp. Pract. - 1992. - Vol. 27, є 10. - P. 189-209.

LucherT.F, Barton M. Biology of the endothelium//Clin. Cardiol. Ч 1997. Ч Vol. 10 (Suppl II).- P. 3-10.

Maenza R.L., Seaberg D., D'Amico F. A meta-analysis ofblunt cardiac trauma: ending myocardial confusion//Amer. J. Emerg. Med. Ч 1996. Ч Vol. 14. Ч P. 237.

Mahapatra R.K., Ellis G.H. Myocarditis and hepatitis ¬ virus // Angiology. Ч 1985.-Vol. 36.-P. 116-118.

Maisch B. The European study of epidemiology and treatment of cardiac inflammatory disease//Europ. Heart J. - 1997.-Vol. 116.Ч P. 1248-1254.

Maisch ¬., Portig I., Ristic A.etal. Definition of inflammatory cardiomyopathy (myocarditis): on the way to Consensus. A status report//Herz. Ч 2000. ЧVol. 25, issue 3.-P. 200-209.

Mallat Z., Tedgui A., Fontaliran F. et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia //New Engl. J. Med. - 1996. - Vol. 335. - P. 1224-1226.

Mann D.L. Mechanisms and models in heart failure: a combination approach // Circulation. - 1999. - Vol. 100. - P. 999-1008.

Manolio T.A., Baughman K.L., Rodeheffer R. et al. Prevalence and etiology of idiopathic dilated cardiomyopathy//Amer. J. Cardiol. Ч 1992. ЧVol.69. Ч P. 1458-1466.

Marcolongo R., Russo R., LavederF. etal. Immunosuppressive therapy prevents recurrent pericarditis // J. Amer. Coll. Cardiol. - 1995. - Vol. 26. - P. 1276.

Marcus F.I., Fontaine G., GuiraudonG. etal. Right ventricular dysplasia: a report of 24 cases //Circulation. - 1982. - Vol. 65. - P. 384-399.

Marcus L.C., Steere A.C., Duray PH. et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis//Ann. Intern. Med. Ч 1985. ЧVol. 103. Ч P. 374-376.

Mason J.W. Distinct forms of myocarditis// Circulation. Ч 1991. Ч Vol. 83. Ч P. 1110Ч1111.

Masui “., Finck S., Higgins C.B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging //Radiology. Ч 1991. ЧVol. 182. Ч P. 369.

Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal disease//Circ. Res. - 1998. - Vol. 83. - P. 1182-1191.

McCarthy R.E., Bochmer J.P., Hruban R.H. et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis // New Engl. J. Med. - 2000. - Vol. 342. - P. 690-694.

McKenna W.J., Thiene G., Nava A. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology//Brit. Heart J. - 1994. - Vol. 71. - P. 215-218.

McManus B.M., Chow L.H., Radio S.J. et al. Progress and challenges in the pathological diagnosis of myocarditis// Eur. Heart J. Ч 1991. ЧVol. 12, Suppl. D. Ч P. 18-21.

MeldrumD.R. Tumour necrosis factor in the heart// Amer. J. Physiol. Ч 1998. Ч Vol. 274.-P. 577-595.

Mendosa I., Camardo J., Moleiro F. et al. Sustained ventricular tachycardia in chronic chagasic myocarditis //Amer. J. Cardiol. Ч 1986. Ч Vol. 57. Ч P. 423-424.

Melchior “.ћ., Ringsdal V., Hildebrandt P. et al. Recurrent acute idiopathic pericarditis treated with intravenous methylprednisolone given as pulse therapy// Amer. Heart J.- 1991. Ч Vol. 123. Ч P. 1086.

Milei J., BortmanG., Fernandez-AlonsoG. etal. Immunohistochemicalstaining of lymphocytes for the reliable diagnosis of myocarditis in endomyocardial biopsies // Cardiology. - 1990. - Vol. 77, є 2. Ч P. 77-85.

Millaire A., de Groote P., Decoulx L. et al. Treatment of recurrent pericarditis with colchicine//Europ. Heart J. - 1994. - Vol. 15. Ч P. 120.

Moores D.W.O., Allen  . ¬., Faber L.P. et al. Subxiphoid pericardial drainage for pericardial tamponade//J. Thorac. Cardiovasc. Surg. Ч 1995. ЧVol. 109. Ч P. 546.

Muller J., 'Vv&llukat G., Dandel M. et al. Immunoglobulin absorption in patients with idiopathic dilated cardiomyopathy//Circulation. Ч 2000. Ч Vol. 101. Ч P. 385-391.

Nabauer M., Kaab S. Potassium channels down-regulation in heart failure // Cardiovasc. Res. - 1998. - Vol. 37. - P. 324-334.

Nagaratnam N., deSilva D.P.K.M., Gunawardene K.R.W. Myocardial involvement in infectious hepatitis//Postgrad. Med. J. Ч 1971. ЧVol.47. Ч P. 785-788.

Narang R., Swedberg K., Cleland J.G. F What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effects of ACE inhibitors on exercise capacity//Europ. Heart J. Ч 1996. Ч Vol. 17. Ч P. 120-134.

Narula J., Haider N., Virmani R. et al. Apoptosis in myocytes in end-stage heart failure // New Engl. J. Med. - 1996. - Vol. 335. - P. 1182-1189.

Nava A., Thiene G., Canciani B. et al. Familial occurrence of right ventricular dysplasia: a study involving nine families // J. Amer. Coll. Cardiol. Ч 1988. Ч Vol. 12.-P. 1222-1228.

NelsonG.S., BergerR.D., FebicsB.J. etal. Left ventricular orbiventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block//Circulation. Ч 2000. Ч Vol. 102. Ч P. 3053-3059.

Nieminen M.A., Heikkila J., Karjalainen J. Echocardiography in acute infectious myocarditis: Relation to clinical and electrocardiographic findings // Amer. J. Cardiol. - 1984. - Vol. 53. - P. 1331-1334.

Niggli E. Ca 2+ sparks in cardiac muscle: is there life without them? // News Physiol. - 1999. - Vol. 14. - P. 129-134.

Nimura H., Bachinski L., Songwatanaroj S. et al. Mutations in the gene for cardiac myosin-binding protein-C and late-onset familial hypertrophic cardiomyopathy// New Engl. J. Med. - 1998. - Vol. 338. - P. 1248-1257.

Nishiyama Y, Ikeda H., Haramaki N. et al. Oxidative stress is related to exercise intolerance in patients with heart failure // Amer. Heart J. Ч 1998. Ч Vol. 135. Ч P. 115-120.

NugueO., Millaire A., Porte H. etal. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients//Circulation. Ч 1996. Ч Vol. 94. Ч P. 1635.

O'Connell J.B. Diagnosis and medical treatment of inflammatory cardiomyopathy// Card. Vase. Dis. - 1998. - Vol. 3. - P. 132-143.

OhJ.K., HatleL., Seward J.B. etal. Diagnostic role of Doppler echocardiography in constrictive pericarditis //J. Amer. Coll. Cardiol. Ч 1994. Ч Vol. 23.Ч P. 154.

Okuno M., Nakagava M., Shimada M. Expressional patterns of cytokines in murine model of acute myocarditis // Lab. Invest. Ч 2000. Ч Vol. 80, є 3. Ч p 433-440.

Oliveira J\S., Correa De Araujo R.R., Navarro M.A. et al. Cardiac thrombosis and thromboembolism in chronic Chagas heart disease //Amer. J. Cardiol. Ч 1983. Ч Vol. 52.-P. 147-152.

Olivetti G., Abbi R., Quaini F. et al. Apoptosis in the failing human heart // New Engl. J. Med. - 1997. - Vol. 336. - P. 1131-1141.

Olsen E.G.J. The value of endomyocardial biopsies in myocarditis and dilated cardiomyopathy//Europ. Heart J. - 1991. - Vol. 12, Suppl. D. - P. 10-12.

Olsen E.G.J., Rose M.L., Meany B. et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value // Europ. Heart J. - 1991. - Vol. 12 (Suppl.D). - P. 56-59.

Opie L.H. Angiotensin converting enzyme inhibition. 3th edition. New York: Wiley-Liss, 1999.-275 p.

Parmley WW Neuroendocrine changes in heart failure and their clinical relevance // Clin. Cardiol.- 1995. - \џ. 18. - P. 440-445.

PaulusW.J., Shah A.M. NO and cardiac diastolic function //Cardiovasc. Res. Ч 1999.-Vol. 43.-P. 595-606.

Permanyer-Miralda G., Sagrista-Sauleda J., Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients // Amer. J. Cardiol. - 1985. - Vol. 56. - P. 623.

Peters N.S., Poole-Wilson Ph.A. Myocarditis-continuing clinical and pathologic confusion//Amer. Heart J. - 1991. - Vol. 121. - P. 942-947.

Pfeffer J.M., Pfeffer M.A. Angiotensin converting enzyme inhibition and ventricular remodelling in heart failure // Amer. J. Med. Ч 1988. Ч Vol. 84, Suppl. «ј. - P. 37-44.

Pichardo J., Palace V, Farahmand F. et al. Myocardial oxidation stress changes during compensated right heart failure in rats // Mol. Cell. Biochem. Ч 1999. Ч Vol. 196.-P. 51-57.

Pinamonti ¬., Singara G., Salvi A. et al. Left ventricular involvement in right ventricular dysplasia//Amer. Heart J. - 1992. - Vol. 123. - P. 711-724.

Piovaccari G., Ferretti R.M., Prati F. et al. Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up //Int. J. Cardiol. ~ 1995. - Vol. 49. - P. 39.

Ponicke K.,Vogelsang M., Heinroth M. et al. Endothelin receptors in the failing and nonfailing human heart//Circulation. - 1998. -Vol.97. Ч P. 744-751.

Post S.R., Hammond H.K., Insel PA. ?-adrenergic receptors and receptor signaling in heart failure // Ann. Rev. Pharmacol. Toxicol. Ч 1999. Ч Vol. 39. Ч P 343-360.

PouleurH.etal. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction // Circulation. Ч 1993. Ч Vol. 88, є 2.- P. 481-491.

Ram P., Chandra M.S. Unusual electrocardiographic abnormality in leptospirosis: Case reports//Angiology. - 1985. - Vol. 36. - P. 477-452.

Ramos H.C., EliasP.R., Barrucand L. etal. The protective effect of carnitine in human diphtheric myocarditis// Pediatr. Res. Ч 1984. Ч Vol. 18. Ч P. 815-817.

Rampazzo A., Nava A., Danieli G.A. et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24 // Hum. Mol. Genet. - 1994. - Vol. 3. - P. 959-962.

Rampazzo A., Nava A., Erne P. et al. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome Iq42Чq43// Hum. Mol. Genet. - 1995. - Vol. 4. - P. 2151-2154.

Rauchhaus M., Doehner W, Francis D.P. et al. Plasma cytokine parameters and mortality in patients with chronic heart failure//Circulation. Ч 2000. Ч Vol. 102. Ч P. 3060-3067.

Recomendations for exercise training in chronic heart failure patients. Working Group Report// Europ.Heart J. - 2001. - Vol. 22. - P. 125-135.

Reddy PS., Curtiss E.L., Uretsky B.A. Spectrum of hemodynamic changes in cardiac tamponade//Am. J.Cardiol.Ч 1990. - Vol. 66. - P. 1487.

Regitz-Zagrosek V, Neuss M., Fleck E. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects // Europ. Heart J. Ч 1995. Ч Vol. 16, Suppl. N.~ P. 86-91.

Report of the WHO/ISFC task force on the definition and classification of cardiomyopaties// Circulation. - 1996. - Vol. 93. - P. 841-842.

Rerkrattanapipat P., Wongpraparut N. Cardiac manifestations of acqured immunodeficiency syndrome // Arch. Intern. Med. Ч 2000. Ч Vol.160, є 5. Ч P. 602-608.

Reynen  . Cardiac myxomas //New Engl. J. Med.Ч 1995.-Vol.333. - P. 1610.

RobbMacLellanW. Death by design//Circ. Res. - 1997. Ч Vol. 81. Ч P. 137-144.

Rodriguez-Artalejo E, Fuallar-Castillon P., Banegas Banegas J.R. et al. Trends in hospitalization and mortality for heart failure in Spain, 1988-1993 // Europ. Heart J. Ч 1997. - Vol. 18. - P. 1771-1779.

Rogg H. Angiotensin II receptor subtypes in human atria and evidence for alteration in patients with cardiac dysfunction//Europ. HeartJ. Ч 1996. ЧVol. 17. Ч P. 1112-1120.

Roig E., Perez-Villa F, Morales M. etal. Clinical implications of increased plasma angiotensin II despite angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure // Europ. Heart J. - 2000. - Vol. 2. - P. 53-57.

RozyckiG.S.,FelicianoD.V, Schmidt J.A. etal. The role of surgeon-performed ultrasound in patients with possible cardiac wounds // Ann. Surg. Ч 1996. Ч Vol. 223.-P. 737.

Rubinstein E.> Carbon — Staphylococcal endocarditis- recommendations for therapy// Clin. Microbiol. Infect. - 1998. - Vol. 4. - P. 27-33.

Rush J., Rajfer S. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure// J. Hypert. - 1993.ЧVol. 11 (Suppl. 3). - S. 69-71.

Saadia R., Levy R.D., Degiannis E. et al. Penetrating cardiac injuries: clinical classification and management strategy//Brit. J. Surg. Ч 1994. ЧVol.81. Ч P. 1572.

Sagrista-Sauleda J., Permanyer-Miralda G., Candell-Riera J. et al. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis //Amer. J. Cardiol. - 1987. -Vol. 59. - P. 961.

Schick E.C. Jr. Nonpenetrating cardiac trauma // Cardiol. Clin. Ч 1995. Ч Vol. 13.-P. 241.

SchinkelA.,BaxJ. Echocardiographic follow-up of Chlamidia psittaci myocarditis// Chest. - 2000. - Vol. 117, є 4. - P. 1203-1205.

Schonian U., Crombach M., Maisch D. Does CMV infection play a role in myocarditis? New aspects from in situ hybridization//Europ. HeartJ. Ч 1991. Ч Vol. 12 (Suppl. D). - P. 65-68.

Sekido M., Takano T, Takayama M. et al. Survey of infective endocarditis in the last 10 years: analysis of clinical, microbiological and therapeutic features // J. Cardiol. Ч 1999.-Vol. 33.-P. 209-215.

Seko Y, Shinkai Y, Kawasaki A. et al. Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B-3 // Circulation. Ч 1991.-Vol. 84.-P. 788-795.